Cargando…

Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease

BACKGROUND: Arylsulfatase A (ARSA), a lysosomal enzyme, has been shown to inhibit the aggregation and propagation of α-synuclein (α-syn) through its molecular chaperone function. The relationship between ARSA levels and Parkinson’s disease (PD) in the Chinese Han population remains controversial, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mingjian, Shi, Xiaoxue, Ma, Jianjun, Sun, Wenhua, Wang, Zhidong, Li, Dongsheng, Zheng, Jinhua, Zhao, Zhenxiang, Gu, Qi, Chen, Siyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349122/ https://www.ncbi.nlm.nih.gov/pubmed/35486332 http://dx.doi.org/10.1007/s10072-022-06093-w

Ejemplares similares

Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson’s disease patients
por: Shi, Xiaoxue, et al.
Publicado: (2022)

Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson’s Disease
por: Sun, Wenhua, et al.
Publicado: (2021)

Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
por: Hu, Shiyu, et al.
Publicado: (2021)

Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson’s disease
por: Shi, Xiaoxue, et al.
Publicado: (2021)

Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study
por: Li, Linyi, et al.
Publicado: (2020)

MicroRNA-181a–2–3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson’s disease by inhibiting EGR1 and NOX4
por: Ma, Jianjun, et al.
Publicado: (2022)

Changes in plasma arylsulfatase A level as a compensatory biomarker of early Parkinson’s disease
por: Yoo, Han Soo, et al.
Publicado: (2020)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of Hypoxia
por: Bhattacharyya, Sumit, et al.
Publicado: (2012)

miR-494-3p Promotes Erastin-Induced Ferroptosis by Targeting REST to Activate the Interplay between SP1 and ACSL4 in Parkinson's Disease
por: Ma, Jianjun, et al.
Publicado: (2022)

Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
por: Liang, Keke, et al.
Publicado: (2023)

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
por: Li, Dongsheng, et al.
Publicado: (2017)

Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice
por: Blomqvist, Maria, et al.
Publicado: (2011)

Protein structure prediction for novel mutations in Arylsulfatase-A gene
por: Divya, M, et al.
Publicado: (2014)

Anti-diabetic activity of different oils through their effect on arylsulfatases
por: Samarji, Rima, et al.
Publicado: (2014)

Decline in arylsulfatase B leads to increased invasiveness of melanoma cells
por: Bhattacharyya, Sumit, et al.
Publicado: (2016)

Arylsulfatase A pseudodeficiency in Mexico: Enzymatic activity and haplotype analysis
por: Juárez‐Osuna, Jesús A., et al.
Publicado: (2020)

A Possible Role for Arylsulfatase G in Dermatan Sulfate Metabolism
por: Poterala-Hejmo, Aleksandra, et al.
Publicado: (2020)

Novel subtype of mucopolysaccharidosis caused by arylsulfatase K (ARSK) deficiency
por: Verheyen, Sarah, et al.
Publicado: (2022)

Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study
por: í Dali, Christine, et al.
Publicado: (2020)

Purification and biosynthesis of a derepressible periplasmic arylsulfatase from Chlamydomonas reinhardtii
Publicado: (1988)

Upregulation of arylsulfatase B in carotid atherosclerosis is associated with symptoms of cerebral embolization
por: Biros, Erik, et al.
Publicado: (2017)

Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes
por: Wright, Teresa, et al.
Publicado: (2018)

Preparation of immobilized arylsulfatase on magnetic Fe(3)O(4) nanoparticles and its application for agar quality improvement
por: Zhang, Chenghao, et al.
Publicado: (2021)

Arylsulfatase B Improves Locomotor Function after Mouse Spinal Cord Injury
por: Yoo, Myungsik, et al.
Publicado: (2013)

Brown Algae and Basalt Meal in Maintaining the Activity of Arylsulfatase of Soil Polluted with Cadmium
por: Zaborowska, Magdalena, et al.
Publicado: (2017)

Inhibition Properties of Arylsulfatase and β-Glucuronidase by Hydrogen Peroxide, Hypochlorite, and Peracetic Acid
por: Zhong, Shu-shu, et al.
Publicado: (2021)

Three novel variants in the arylsulfatase A (ARSA) gene in patients with metachromatic leukodystrophy (MLD)
por: Hettiarachchi, D., et al.
Publicado: (2019)

Arylsulfatase B Regulates Versican Expression by Galectin-3 and AP-1 Mediated Transcriptional Effects
por: Bhattacharyya, Sumit, et al.
Publicado: (2013)

Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase): Potential Role as a Biomarker in Prostate Cancer
por: Feferman, Leo, et al.
Publicado: (2013)

Correction to: Three novel variants in the arylsulfatase A (ARSA) gene in patients with metachromatic leukodystrophy (MLD)
por: Hettiarachchi, D., et al.
Publicado: (2020)

Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes
por: Hendrickx, Gretl, et al.
Publicado: (2020)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect
por: Bhattacharyya, Sumit, et al.
Publicado: (2016)

Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK‐611) in Children With Metachromatic Leukodystrophy
por: Troy, Steven, et al.
Publicado: (2020)

Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases
por: Tobacman, Joanne K., et al.
Publicado: (2022)

Gastrointestinal Carcinoma with Plasmacytoid Morphology: Positivity for c-MET, Arylsulfatase, and Markers of Epithelial-Mesenchymal Transition, as Indicators of Aggressivity
por: Kovacs, Zsolt, et al.
Publicado: (2019)

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia
por: Tang, Yilin, et al.
Publicado: (2023)

Case Report: Novel Arylsulfatase A (ARSA) Gene Mutations in a Patient With Adult-Onset Metachromatic Leukodystrophy Misdiagnosed as Multiple Sclerosis
por: Xu, Lulu, et al.
Publicado: (2021)

Characterization of the arylsulfatase I (ARSI) gene preferentially expressed in the human retinal pigment epithelium cell line ARPE-19
por: Oshikawa, Mio, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ilsmt8qpg1i15sh6r81id4lg0o